Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

NVP Healthcare

Status and phase: Completed; Phase 1

Conditions: Dyslipidemia

Treatments: Drug: rosuvastatin and ezetimibe; Drug: NVP-1205

Study type: Interventional

Funder types: Industry

Identifiers

NCT02029625

NVP-1205-01

Details and patient eligibility

About

The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.

Full description

rosuvastatin and ezetimibe(anti-dyslipidemia)

Enrollment: 41 patients

Sex: Male

Ages: 19 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male subjects age between 19 and 55 signed informed consent

Exclusion criteria

• subjects have a history of allergy reaction of this drug or other drugs

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

41 participants in 2 patient groups

NVP-1205

Experimental group

Description:

administration of NVP-1205(rosuvastatin+ezetimibe)

Treatment:

Drug: NVP-1205

rosuvastatin and ezetimibe

Active Comparator group

Description:

coadministration of rosuvastatin and ezetimibe

Treatment:

Drug: rosuvastatin and ezetimibe